hat had resulted in Anaphylaxis previously and the "Cause for concern" for the medication Olanzapine. EFTA00263320 The patient, was diagnosed as Acute Allergic Oedema to the Covid-19 Immunisation administered on the 8th February 2022 at the RAH Specialist Vaccination Clinic at 10.33am by K Jones • nal medical ad